Mic-ag

Liofilchem® - MIC Test Strip APPLICATION GUIDE - Rev.6 / 22.04.2013
MIC Test Strip Application Guide
INOCULUM
INCUB TION 36
TION 36 1°C
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL 1)
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL
PHENOTYPE
PHENOTYPE
TURBIDITY
SUSPENSION
ATMOSPHERE
Staphylococci
Liofilchem® - MIC Test Strip APPLICATION GUIDE - Rev.6 / 22.04.2013
INOCULUM
INCUB TION 36
TION 36 1°C
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL 1)
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL
PHENOTYPE
PHENOTYPE
TURBIDITY
SUSPENSION
ATMOSPHERE
Enterococci
Enterobacteriaceae
Enterobacteriaceae
Pseudomonas spp.
Acinetobacter spp.
Liofilchem® - MIC Test Strip APPLICATION GUIDE - Rev.6 / 22.04.2013
INOCULUM
INCUB TION 36
TION 36 1°C
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL 1)
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL
PHENOTYPE
PHENOTYPE
TURBIDITY
SUSPENSION
ATMOSPHERE
Burkholderia cepacia
Stenotrophomonas
malthophila
FASTIDIOUS
Pneumococci
Streptococci
Haemophilus spp.
Anaerobes

Liofilchem® - MIC Test Strip APPLICATION GUIDE - Rev.6 / 22.04.2013
INOCULUM
INCUB TION 36
TION 36 1°C
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL 1)
MICROORGANISM
SPECIFIC
SUGGESTED M.I.C. PANEL
PHENOTYPE
PHENOTYPE
TURBIDITY
SUSPENSION
ATMOSPHERE
Helicobacter pylori
LZ first 24 h anaerobic Tetracycline (TE) Gonococci
Meningococci
Campylobacter spp.
(1 Fusarium/Rizopus spp.) + Tween 80 (ref. 80031) CLSI M100-S23 Performance Standards for Antimicrobial Susceptibility Testing, January 2013.
CLSI M27-A3 Reference method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - Third Edition.
CLSI M27-S4 Reference method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement.
MIC Test Strip Patent No. 1395483
2. EUCAST disk diffusion method, Version 2.1, February 2012.
Liofilchem® and the Liofilchem company logo are registered trademarks of LIOFILCHEM s.r.l.
LIOFILCHEM® s.r.l.
Via Scozia zona ind.le, 64026 Roseto degli ia Scozia zona ind.le, 64026 Roseto degli

Source: https://www.biovendor.cz/download/2020/Aplikace_MIC.pdf

Schizophrenia

Schizophrenia Schizophrenia is a brain disorder that impairs a person’s ability to think clearly, manage his or her emotions, make decisions and relate to others. Like cancer or diabetes, it is a complex chronic medical illness affecting different people in different ways. It is not caused by bad parenting or personal weakness, but appears to be a result of problems with brai

Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials

Cerebral palsy (CP) has an incidence and prevalence rate ofabout two per 1000 in children (Grether et al.1992, Yeargin-Allsopp et al. 1992). Spasticity is a major clinical feature of over75% of cases of CP and is conventionally considered to be amajor cause of discomfort, gait abnormalities, and function-al limitations for persons with CP. Many resources have beendirected at the treatment of spa